November 5, 2007 – Boston Scientific Corp. highlighted at the American Heart Association conference its new Stentplus ...
November 5, 2007 - A pooled analysis of the E-SIRIUS and C-SIRIUS trials, called New SIRIUS, found that the CYPHER sirolimus-eluting coronary stent continued to provide clinical benefits with similar safety compared to a bare metal stent at five-year follow-up, according to data presented at the American Heart Association Scientific Session 2007.
November 5, 2007 - Pinyons Medical Technology announced it received FDA clearance to market the PowrSyringe Injector, a ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Pinyons Medical Technology offers the FDA-cleared PowrSyringe Injector, a disposable hand-held device designed to offer ergonomic and mechanical advantages to inject and aspirate fluids including use in angiography. The Injector’s crossing handles hinge to the syringe barrel and plunger to advance the plunger into the barrel when the handles are squeezed.
November 5, 2007 - According to late-breaking clinical trial results presented at the American Heart Association’s ...
November 4, 2007 - A small, implantable device that helps the heart pump blood works equally well for men and women but ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
November 4, 2007 – A specific way of dosing eptifibatide appears equally effective as giving abciximab as an adjunct to ...
November 4, 2007 – The antiplatelet drug prasugrel offered greater benefit than current, standard therapy for patients ...
November 4, 2007 – Drug-eluting stents to open blocked coronary arteries caused no more risks for death or heart attack than bare metal stents, according to a late-breaking outcomes trial presented at the American Heart Association’s Scientific Sessions 2007.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
November 4, 2007 - The prevalence of asymptomatic peripheral artery disease (PAD) is steadily increasing among American ...
November 4, 2007 – Single photon emission computed tomography (SPECT) can identify which patients will benefit more from undergoing percutaneous coronary intervention (PCI) than receiving medical therapy alone for blocked coronary arteries, according to late-breaking clinical trial results presented at the American Heart Association’s Scientific Sessions 2007.
ATS Medical Inc., manufacturer and marketer of state-of-the-art cardiac surgery products and services, received FDA ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Ovalum Ltd., a privately held Israeli medical device company, has received FDA marketing clearance for the CiTop ...
Apollo Medical Imaging Technology’s MIStar multipurpose software reportedly combines a broad spectrum of advanced ...
November 1, 2007 - TeraRecon, a provider of advanced visualization solutions, received the Frost & Sullivan 2007 Market ...
November 04, 2007
